Literature DB >> 4454033

Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.

G Sas, G Blaskó, D Bánhegyi, J Jákó, L A Pálos.   

Abstract

A family with a high incidence of spontaneous thromboembolism has been investigated and those members affected were found to have significantly depressed levels of plasma and serum heparin cofactor activity; i.e., antithrombin III and anti-Xa activity. Further studies revealed that despite a marked diminution of antithrombin III activity in these patients measurement of antithrombin III by immunological techniques showed the levels to be normal. It is concluded that this anomaly represents a defect in the synthesis of the antithrombin III molecule. The abnormality appeared to be inherited but the mode of inheritance could not be determined with the available data.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4454033

Source DB:  PubMed          Journal:  Thromb Diath Haemorrh        ISSN: 0340-5338


  18 in total

1.  Effect of experimental inflammation on the synthesis and distribution of antithrombin III and alpha1-antitrypsin in rabbits.

Authors:  A Koj; E Regoeczi
Journal:  Br J Exp Pathol       Date:  1978-10

2.  Associated von Willebrand disease as a possible cause of lack of thrombosis in an AT III abnormality (AT III Trento).

Authors:  A Girolami; M G Cappellato; M A Vicarioto; S Casonato; F Marafioti
Journal:  Blut       Date:  1986-01

3.  Evidence linking familial thrombosis with a defective antithrombin III gene in two British kindreds.

Authors:  S H Sacks; J M Old; S T Reeders; D J Weatherall; A S Douglas; J H Winter; C R Rizza
Journal:  J Med Genet       Date:  1988-01       Impact factor: 6.318

4.  Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").

Authors:  J E Sambrano; L J Jacobson; E B Reeve; M J Manco-Johnson; W E Hathaway
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

Review 5.  Familial venous thrombosis.

Authors:  J H Winter; A S Douglas
Journal:  Postgrad Med J       Date:  1983-11       Impact factor: 2.401

6.  Deficiency of antithrombin III in children with hemolytic-uremic syndrome.

Authors:  B Roth; T von Lilien; B Busch; A Gillor; M Bulla
Journal:  Eur J Pediatr       Date:  1984-04       Impact factor: 3.183

7.  Familial thrombosis: inherited deficiency of antithrombin III.

Authors:  M Mackie; B Bennett; D Ogston; A S Douglas
Journal:  Br Med J       Date:  1978-01-21

8.  Cloning and expression of the cDNA for human antithrombin III.

Authors:  S C Bock; K L Wion; G A Vehar; R M Lawn
Journal:  Nucleic Acids Res       Date:  1982-12-20       Impact factor: 16.971

9.  Antithrombin III (AT III) Padua2: a "new" congenital abnormality with defective heparin co-factor activities but no thrombotic disease.

Authors:  A Girolami; F Fabris; G Cappellato; L Sainati; G Boeri
Journal:  Blut       Date:  1983-08

10.  Relation between antithrombin III and clinical and serological parameters in systemic lupus erythematosus.

Authors:  M P Jarrett; D Green; C H Ts'ao
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.